U.S. Auto Stock News

Strategic Education (STRA) recently posted a third quarter earnings report showing higher revenue and greater profitability, mainly supported by steady growth from its Sophia Learning and Workforce Edge platforms. Management highlighted ongoing operational efficiencies and robust employer-affiliated enrollments as positive trends. See our latest analysis for Strategic Education. Alongside the solid earnings beat, Strategic Education has been active with its buyback program, repurchasing...

NextDecade (NEXT) is drawing renewed attention after Hanwha Aerospace boosted its position by acquiring nearly 592,000 shares. At the same time, the company advanced its Rio Grande LNG project with final investment decisions and $13.4 billion in project funding. See our latest analysis for NextDecade. NextDecade’s recent operational milestones and insider buying have helped steady investor sentiment, even as near-term share price performance remains volatile. Despite a sharp pullback with a...

Impinj (PI) shares have faced pressure over the past month, with the stock declining nearly 29%. Investors seem to be weighing the company’s fundamentals and considering whether current levels could present a potential long-term opportunity. See our latest analysis for Impinj. After a long stretch of gains, Impinj’s 1-year total shareholder return is now down 19.3% as momentum cooled sharply in recent weeks. While the latest 1-month share price return of -29.3% captures the recent slide, the...

Ulta Beauty (ULTA) shares caught investor attention as the company announced it will end its long-running shop-in-shop partnership with Target in August 2026 and opened its first standalone store in the Middle East. These business moves could shape Ulta's growth outlook going forward. See our latest analysis for Ulta Beauty. Ulta Beauty's share price has gained solid momentum this year, with a 23.3% share price return year-to-date and a strong 44.96% total shareholder return over the past...

Apogee Therapeutics (APGE) is in the spotlight after sharing positive interim data from its Phase 1 trial of APG333. The experimental antibody showed a longer half-life and favorable safety profile in healthy volunteers. See our latest analysis for Apogee Therapeutics. Momentum around Apogee Therapeutics has been building fast, with the 1-day share price return jumping 4% after upbeat Phase 1 trial results and a successful $345 million capital raise. That excitement has fueled a striking...

Agios Pharmaceuticals announced that new clinical and preclinical data on mitapivat, its oral pyruvate kinase activator, were featured in multiple presentations at the 67th American Society of Hematology (ASH) Annual Meeting held in Orlando from December 6-9, 2025. The presentations highlighted mitapivat's potential to significantly reduce transfusion needs in thalassemia and provided early evidence of protection against heart complications, an important concern for patients with hemolytic...

Molson Coors Beverage (TAP) stock dipped slightly this week, catching some attention from investors tracking longer-term trends. Shares have drifted nearly 19% lower since January, raising questions about the outlook and underlying factors shaping its trajectory. See our latest analysis for Molson Coors Beverage. Molson Coors Beverage’s share price has steadily lost ground over the last year, closing recently at $46.44, and momentum seems to be fading after a string of weaker total...

Organon & Co. recently reported third quarter 2025 earnings, showing sales of US$1.60 billion and net income of US$160 million, while also lowering its full-year revenue guidance to a range of US$6.20 billion to US$6.25 billion. The company's latest results reflected a significant drop in net income compared to the prior year, signaling that margin pressures and revised expectations are influencing its financial outlook. We'll explore how Organon's reduced full-year revenue outlook and...

BlackLine (BL) released its third quarter results, showing higher revenue from last year; however, net income and earnings per share moved lower. The company also issued fresh revenue guidance for the upcoming quarter and year. See our latest analysis for BlackLine. BlackLine’s latest earnings update and new revenue guidance came just as the share price was working to recover from a bumpy first half of the year. While the 1-month share price return of 9.7% suggests recent momentum is...

Advanced Micro Devices (AMD) grabbed attention at its recent Analyst Day by unveiling bold financial targets for the next several years. Management forecasted over 35% compound annual revenue growth, supported by strong demand for AI infrastructure chips. See our latest analysis for Advanced Micro Devices. Momentum has really built around AMD this year, with the stock notching a 104.6% year-to-date share price return and a one-year total shareholder return of nearly 83%. Fueling the gains,...

Broadstone Net Lease recently achieved substantial completion on the first of two MRO hangars at Dayton International Airport, supporting Sierra Nevada Corporation’s contract with the U.S. Air Force, while also advancing new build-to-suit projects for Hobby Lobby and Academy Sports. This wave of project launches and tenant-driven real estate development underscores BNL’s ability to secure high-value, mission-critical assets with stable, long-term rental streams. Let’s explore how the...

Arcutis Biotherapeutics recently announced the completion of patient enrollment in its INTEGUMENT-INFANT Phase 2 study of ZORYVE cream for atopic dermatitis in infants, alongside the publication of positive long-term safety and efficacy results for ZORYVE foam in seborrheic dermatitis. ZORYVE is now distinguished as a multi-award-winning, FDA-approved topical treatment with growing clinical endorsements and expanded indications across pediatric and adult dermatology populations. We'll...

Bruker Corporation recently reported a third quarter net loss of US$62.4 million and a 0.5% year-over-year decrease in sales, alongside a US$96.5 million goodwill impairment charge and a lowered financial outlook for fiscal 2025. Despite ongoing challenges, Bruker’s Board approved quarterly dividends for both common and preferred shareholders, highlighting a commitment to shareholder returns amid financial headwinds. We'll explore how the lowered financial outlook and substantial goodwill...

Earlier this month, Pathward Financial announced a partnership with Upstart Holdings to offer personal loans through Upstart's AI-driven lending marketplace, shortly after Upstart reported third-quarter revenue of US$277.11 million and net income of US$31.81 million. This flurry of activity included optimistic guidance for the full year and a major insider stock purchase by a top executive, signaling heightened confidence in Upstart's approach to financial technology and lending...

Teledyne Technologies (TDY) is drawing attention after unveiling its latest space-grade CMOS image sensors and revealing plans to open a new regional headquarters in Riyadh. These developments highlight the company’s efforts to expand into advanced imaging solutions and grow its regional presence. See our latest analysis for Teledyne Technologies. Following these product launches and Teledyne’s expansion in the Middle East, recent momentum has softened, with the share price retreating 10.85%...

Hasbro (HAS) just delivered third-quarter earnings that beat expectations, fueled by a strong showing from its MAGIC: THE GATHERING brand and cost-saving measures. Investors seem to be responding positively to this momentum. See our latest analysis for Hasbro. Hasbro’s latest results arrive after a string of upbeat headlines, including a high-profile holiday collaboration with Duluth Trading and the relaunch of classic Transformers collectibles. The stock’s share price has climbed 37.7%...

Sana Biotechnology reported its third quarter earnings, posting a reduced net loss compared to a year ago. This narrowing loss could signal progress in tightening costs and moving towards improved financial health. See our latest analysis for Sana Biotechnology. Sana Biotechnology’s share price has seen some major swings recently, with a one-day jump of over 9% right after earnings. Even with a 21% drop over the last month, the stock’s 90-day share price return sits at a solid 17%, and its...

Atlas Energy Solutions Inc. recently suspended its quarterly dividend and reported a net loss for the third quarter, alongside a drop in revenue to US$259.61 million from US$304.43 million a year ago. At the same time, the company announced a major order for 240 megawatts of power generation equipment, signaling an increased commitment to expanding its power solutions business for a more diversified customer base. We will explore how these recent earnings results and the dividend suspension...

MINISO Group Holding Limited recently experienced a decline in its unsponsored ADR shares, underperforming the broader market as investors turned their attention to its upcoming earnings report scheduled for November 21, 2025. Market anticipation is being fueled by consensus estimates that project strong year-over-year revenue growth, even as analyst sentiment and earnings forecasts have remained largely unchanged. With investor focus on the anticipated revenue growth, we’ll explore what...

Freshworks (FRSH) posted impressive third-quarter numbers, topping estimates for both revenue and profits. The company also boosted its 2025 outlook and showcased new AI-driven features across core products, catching the attention of investors. See our latest analysis for Freshworks. After a challenging stretch earlier this year, Freshworks’ 1-month share price return of 11% suggests positive momentum is returning, especially following upbeat earnings and a wave of AI-focused product...

DaVita (DVA) has landed in the spotlight after Jim Cramer pointed to regulatory jitters in the healthcare sector. Fresh Senate legislation and subsidy concerns are unsettling stocks, and a recent earnings miss has added to the cautious atmosphere around DaVita. See our latest analysis for DaVita. Recent headlines and a string of clinical updates have not been enough to spark a turnaround for DaVita’s share price. Over the past year, the stock saw a 24.2% decline in total shareholder return,...

On November 5, 2025, Lemonade, Inc. reported third quarter results showing US$194.5 million in revenue and a net loss of US$37.5 million, while also raising its full year 2025 guidance amid strong year-to-date performance. Management's raised outlook and improving losses highlight operational progress and increasing confidence in Lemonade's ongoing digital insurance expansion. We'll examine how Lemonade's upgraded 2025 guidance and narrowing losses could alter the company's outlook amid...

Dolby Laboratories (DLB) has caught the market’s attention as investors weigh its recent performance. With shares shifting slightly this week, many are considering how recent trends will play into the company’s valuation in the coming months. See our latest analysis for Dolby Laboratories. While Dolby Laboratories' share price has slipped 4.6% over the past month and remains down more than 15% year-to-date, its one-year total shareholder return tells a slightly firmer story, with losses less...

Par Pacific Holdings (PARR) just delivered a surge in net income for both its third quarter and the past nine months, even as sales slipped compared to last year. Investors seem to be paying close attention as sentiment shifts more positive. See our latest analysis for Par Pacific Holdings. Par Pacific Holdings’ strong profit rebound and share buybacks seem to have caught investors’ attention, with momentum gathering pace. The stock has delivered a 24.1% share price return over the past month...